Form 4: Praxis Precision Medicines CEO Marcio Souza Acquires 185,000 Stock Options
SEC Form 4 Filing
Praxis Precision Medicines CEO Marcio Souza acquired 185,000 stock options on July 29, 2024, according to a Form 4 filing with the SEC.
Summary
- According to a Form 4 filing with the SEC, Marcio Souza, the CEO of Praxis Precision Medicines, Inc. acquired 185,000 stock options on July 29, 2024.
- The exercise price of these options is $56.94.
- The options vest over a period of 48 months, with 7/48ths vesting immediately on July 29, 2024, and the remaining shares vesting in substantially equal monthly installments over the following 41 months, contingent upon continued service.
- The options expire on July 29, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard executive compensation practice, and the vesting schedule aligns management's interests with shareholders.
Positives
- The CEO's acquisition of stock options may signal confidence in the company's future performance.
Future Outlook
The vesting schedule of the stock options incentivizes the CEO to remain with the company for the next 41 months.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO to drive company performance.
- Employees may see the CEO's stock options as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 07/29/2024 | Date of the stock option grant and initial vesting of 7/48ths of the shares. |
| 07/29/2034 | Expiration date of the stock options. |
| 07/31/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.